Explore by Therapeutic Area
TA-Specific Benefit-Risk Solutions
Each therapeutic area has dedicated data pipelines, AI models trained on TA-specific safety patterns, and regulatory output templates aligned with the latest guidance.
Oncology
Complex safety profiles, biomarker-driven therapies, accelerated approvals, and immunotherapy combinations.
Neurology
Neurodegenerative disease BRA, CNS safety monitoring, and long-term outcome modeling.
Immunology
Autoimmune disease benefit-risk, immunosuppression safety profiles, and biologic therapy monitoring.
Cardiology
Cardiovascular outcome trials, arrhythmia risk modeling, and heart failure therapy assessment.
Respiratory
Pulmonary safety analysis, inhaled therapy BRA, and rare lung disease modeling.
Rare Diseases
Small-population BRA, gene therapy safety, and accelerated approval pathway support.
Dermatology
Skin disease benefit-risk, biologic safety in dermatology, and topical vs systemic therapy comparison.
Hematology
Blood cancer and blood disorder BRA, CAR-T safety monitoring, and transfusion-dependent disease analysis.
Gastroenterology
IBD benefit-risk analysis, GI safety profiling, and mucosal healing outcome modeling.
Endocrinology
Metabolic disease BRA, diabetes cardiovascular risk modeling, and weight management safety analysis.
Infectious Disease
Antiviral therapy BRA, resistance pattern analysis, and long-term treatment safety monitoring.
Pediatrics
Age-appropriate dosing safety, pediatric-specific adverse event modeling, and developmental outcome tracking.
Platform Architecture
Tailored to Your Therapeutic Area
ArcaScience's three integrated modules adapt to each therapeutic area's unique data landscape, safety patterns, and regulatory requirements.
Domain-Specific Knowledge
Pre-built disease models with TA-specific safety parameters, efficacy benchmarks, and regulatory precedents. Curated data pipelines for each therapeutic area ensure comprehensive, up-to-date evidence.
Explore Data Engine →Adaptive AI Models
AI models trained on TA-specific literature, trial data, and post-marketing evidence for each disease area. Signal detection algorithms tuned for each therapeutic area's unique adverse event profiles.
Explore AI Models →Regulatory-Ready Outputs
Pre-formatted outputs aligned with TA-specific regulatory requirements and submission standards. Templates configured for FDA, EMA, and PMDA requirements in each therapeutic area.
Explore Outputs →